Distance from an urban sickle cell center and its effects on routine healthcare management and rates of hospitalization

Hemoglobin

Volumn 40, Issue 1, 2016, Pages 10-15

  Smeltzer, Matthew P ^a   Nolan, Vikki G ^a   Yu, Xinhua ^a   Nottage, Kerri A ^b   Wang, Winfred C ^b   Hankins, Jane S ^a,b   Gurney, James G ^a,b  

^a UNIVERSITY OF MEMPHIS   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Distance; hospitalization; sickle cell disease

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE MANAGEMENT; HEALTH CENTER; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MONTE CARLO METHOD; MULTICENTER STUDY; SICKLE CELL ANEMIA; TRAVEL; UNITED STATES; URBAN AREA; ANEMIA, SICKLE CELL; HOSPITAL; PRESCHOOL CHILD; TENNESSEE;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; MONTE CARLO METHOD; TENNESSEE;

EID: 84954360723     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2015.1084315     Document Type: Article

References (20)

1. Serjeant GR, Serjeant BE. Sickle Cell Disease. Oxford, UK: Oxford University Press, 2001
2. National Heart, Lung and Blood Institute. Sickle cell anemia, key points. http://www.nhlbi.nih.gov/health//dci/Diseases/Sca/SCA-Summary.html (accessed December 10 2013)
3. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996; 13 (5): 501-512
4. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010; 115 (26): 5300-5311
5. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991; 325 (1): 11-16
6. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010; 303 (13): 1288-1294
7. Hemker BG, Brousseau DC, Yan K, et al. When children with sickle-cell disease become adults: Lack of outpatient care leads to increased use of the emergency department. Am J Hematol. 2011; 86 (10): 863-865
8. Raphael JL, Shetty PB, Liu H, et al. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality. Pediatr Blood Cancer. 2008; 51 (5): 647-651
9. Zielinski A, Borgquist L, Halling A. Distance to hospital and socioeconomic status influence secondary health care use. Scand J Prim Health Care. 2013; 31 (2): 83-88
10. Billi JE, Pai CW, Spahlinger DA. The effect of distance to primary care physician on health care utilization and disease burden. Health Care Manage Rev. 2007; 32 (1): 22-29
11. Buchanan RJ, Stuifbergen A, Chakravorty BJ, et al. Urban/rural differences in access and barriers to health care for people with multiple sclerosis. J Health Hum Serv Admin. 2006; 29 (3): 360-375
12. Sibley LM, Weiner JP. An evaluation of access to health care services along the rural-urban continuum in Canada. BMC Health Serv Res. 2011; 11: 20
13. Skinner AC, Slifkin RT. Rural/urban differences in barriers to and burden of care for children with special health care needs. J Rural Health. 2007; 23 (2): 150-157
14. Andemariam B, Owarish-Gross J, Grady J, et al. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care. Pediatr Blood Cancer. 2014; 61 (4): 697-701
15. Frome EL. The analysis of rates using Poisson regression models. Biometrics. 1983; 39 (3): 665-674
16. Frome EL, Checkoway H. Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985; 121 (2): 309-323
17. Lash T, Matthew P, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. New York, NY: Springer New York, 2009
18. Nottage KA, Hankins JS, Smeltzer M, et al. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PloS One. 2013; 8 (8): e72077. doi 10.1371/journal.pone.0072077
19. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011; 377 (9778): 1663-1672
20. Mueller BU. When should hydroxyurea be used for children with sickle cell disease? Pediatrics. 2008; 122 (6): 1365-1366